BioPharma
Asia’s Bio Sovereignty: Nations Reclaiming Biologics Control
The biopharmaceutical industry in the Asia-Pacific area has seen a significant strategic shift in recent years; this trend is now commonly acknowledged as Asia's bio...
BioPharma
Digital Twins in Biomanufacturing: APAC’s Leap in Innovation
The Asia-Pacific (APAC) region is fast embracing biomanufacturing, leading-edge technology that is poised to redefine manufacturing processes and efficiency. One of the most revolutionary of...
BioPharma
AI Drug Discovery Transforming APAC Biopharma Innovation
The Asia-Pacific (APAC) biopharmaceutical space is being revolutionized by the tremendous progress made in artificial intelligence (AI). The use of AI technologies to drive drug...
Business & Industry
API China, PHARMCHINA & NHNE 2025 Conclude with Global...
API China, PHARMCHINA & NHNE 2025 Close in Guangzhou with Thumping Success, Solidifying China as a World Pharma Leader
Guangzhou, May 24, 2025 — In a...
Business & Industry
Fangzhou Inc. at PHARMCHINA Showcases AI-Powered Healthcare
The 4th Annual "Internet + Pharma" Service Innovation Conference, which was part of the 90th PHARMCHINA event in Guangzhou, was greatly impacted by Fangzhou Inc.,...
Drug Research
Viva Biotech Launches the AI-Driven Drug Discovery Platform, Transforming...
Artificial intelligence has rapidly evolved from academic theory into a transformative force in pharmaceutical R&D. From early QSAR models to neural networks, and now to...
BioPharma
Fluid Path Integrity: Ensuring Purity in Biomanufacturing
In the high-stakes arena of biomanufacturing, where tiny contaminants can have macroscopic effects, the idea of fluid channel integrity has developed from an operational need...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.